Lytix Biopharma AS (LYTIX) — Capital Reinvestment Ratio

Latest as of September 2021: 0.00x

Lytix Biopharma AS (LYTIX) has a Capital Reinvestment Ratio of 0.00x as of September 2021, meaning it reinvests 0% of its operating cash flow (Nkr138.23 Million) in capital expenditures (Nkr35.00K). Check Lytix Biopharma AS tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

Nkr138.23 Million
NOK

Capital Expenditures

Nkr35.00K
NOK

Data as of

Sep 2021
Most recent filing

Annual Capital Reinvestment Ratio for Lytix Biopharma AS (None–None)

Year-by-year Capital Reinvestment Ratio for Lytix Biopharma AS from None to None. See cash generation quality of Lytix Biopharma AS to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (NOK) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow